| answer text |
<p>Patients with pulmonary fibrosis are cared for by National Health Service regional
specialist Interstitial Lung Disease (ILD) services, who are commissioned by NHS England.
To be referred to a specialist service patients need to be identified in primary and
secondary care. Early and accurate diagnosis is a priority for NHS England, and the
work to improve this area of clinical care is underway, which should have an impact
on reducing delayed diagnosis of pulmonary fibrosis.</p><p>NHS England is responsible
for the commissioning of services for ILD and funds the cost of anti-fibrotic treatments
to treat this disease. Access to these treatments has recently been expanded to patients
with non-idiopathic pulmonary fibrosis following the publication of the National Institute
for Health and Care Excellence’s technology appraisal ‘Nintedanib for treating progressive
fibrosing interstitial lung diseases’ in November 2021.</p><p>The Department has no
plans for an awareness campaign.</p>
|
 |
